Saturna Capital CORP maintained its stake in shares of Clorox Company (The) (NYSE:CLX) during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 290,405 shares of the company’s stock at the end of the first quarter. Saturna Capital CORP owned about 0.23% of Clorox Company (The) worth $39,155,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of CLX. FMR LLC raised its stake in shares of Clorox Company (The) by 8.1% in the fourth quarter. FMR LLC now owns 97,861 shares of the company’s stock valued at $11,746,000 after buying an additional 7,357 shares in the last quarter. Thrivent Financial for Lutherans increased its stake in shares of Clorox Company (The) by 5.5% in the fourth quarter. Thrivent Financial for Lutherans now owns 4,565 shares of the company’s stock valued at $548,000 after buying an additional 240 shares in the last quarter. Quadrature Capital Ltd increased its stake in shares of Clorox Company (The) by 1,044.0% in the fourth quarter. Quadrature Capital Ltd now owns 94,059 shares of the company’s stock valued at $11,292,000 after buying an additional 85,837 shares in the last quarter. HighPoint Advisor Group LLC increased its stake in shares of Clorox Company (The) by 3.0% in the fourth quarter. HighPoint Advisor Group LLC now owns 43,247 shares of the company’s stock valued at $5,509,000 after buying an additional 1,245 shares in the last quarter. Finally, Kentucky Retirement Systems purchased a new stake in Clorox Company (The) during the fourth quarter valued at about $1,121,000. Hedge funds and other institutional investors own 70.56% of the company’s stock.
Shares of Clorox Company (NYSE CLX) traded down 0.18% during midday trading on Friday, hitting $134.49. 750,794 shares of the stock were exchanged. The firm has a 50-day moving average price of $134.79 and a 200-day moving average price of $133.07. Clorox Company has a 12-month low of $111.24 and a 12-month high of $141.76. The company has a market cap of $17.32 billion, a PE ratio of 26.57 and a beta of 0.40.
Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.49 by $0.04. The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The firm’s revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period last year, the business earned $1.30 EPS. On average, equities analysts predict that Clorox Company will post $5.69 EPS for the current year.
The firm also recently declared a quarterly dividend, which was paid on Friday, August 4th. Stockholders of record on Wednesday, July 19th were given a $0.84 dividend. This is an increase from Clorox Company (The)’s previous quarterly dividend of $0.80. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.50%. The ex-dividend date was Monday, July 17th. Clorox Company (The)’s dividend payout ratio (DPR) is presently 63.04%.
A number of research analysts recently weighed in on the stock. UBS AG reaffirmed a “sell” rating and issued a $121.00 price target (up from $117.00) on shares of Clorox Company (The) in a research note on Friday, May 5th. BidaskClub upgraded shares of Clorox Company (The) from a “strong sell” rating to a “sell” rating in a report on Monday, July 31st. BMO Capital Markets set a $150.00 target price on shares of Clorox Company (The) and gave the company a “buy” rating in a report on Thursday. Barclays PLC dropped their price target on shares of Clorox Company (The) from $140.00 to $136.00 and set an “equal weight” rating for the company in a research note on Friday. Finally, Zacks Investment Research cut shares of Clorox Company (The) from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company’s stock. Clorox Company (The) currently has a consensus rating of “Hold” and a consensus price target of $129.13.
About Clorox Company (The)
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.
